PARProceedings of Anticancer Research2208-35452208-3553Bio-Byword Scientific Publishing Pty. Ltd.10.26689/PAR.v10i5.15997ArticleSkeletal Muscle as a Trainable Anticancer Endocrine Organ: Integrating Myokines, Exercise-Derived Extracellular Vesicles, and Immunometabolic Reprogramming in Exercise Oncologyhttps://artdesignp.com/journal/PAR/10/5/10.26689/PAR.v10i5.15997ChenJingyu20261052026-10-15Exercise oncology has moved from epidemiological association to mechanistic science, yet contracting skeletal muscle is still treated in most oncological models as a bystander rather than as an active regulator of tumour biology. This review integrates evidence from prospective cohorts, controlled exercise trials, tumour-bearing animal models and human ex vivo serum and extracellular vesicle (EV) studies into a single three-level muscle-tumour crosstalk axis. At the first level, repeated contraction remodels the muscle secretome, releasing soluble myokines and EV cargo that act directly on neoplastic cells. At the second level, each exercise bout—and, cumulatively, its chronic repetition—reshapes systemic immunometabolic conditions: immune-cell trafficking, catecholamine and substrate availability, insulin signalling and low-grade inflammation. At the third level, these systemic changes converge on the tumour microenvironment, altering immune infiltration, vascular function, hypoxia, drug delivery and proliferative signalling. The same axis is supported in reverse by the consistent prognostic weight of sarcopenia and cancer cachexia. The 2025 CHALLENGE trial, which improved disease-free survival after adjuvant therapy for colon cancer, supplies the first survival-grade clinical evidence. The review closes with a mechanism-informed prescription framework and a ranked set of unresolved questions concerning EV standardisation, dose-response, tumour-type specificity and synergy with immunotherapy.Cancer survivorship, Tumour microenvironment, Exerkines, Natural killer cells, Sarcopenia, Exercise prescription, Immunotherapy

[1]   Moore SC, Lee I-M, Weiderpass E, et al., 2016, Association of Leisure-Time Physical Activity with Risk of 26 Types of Cancer in 1.44 Million Adults. JAMA Internal Medicine, 176(6): 816–825. [2]   Kerr J, Anderson C, Lippman SM, 2017, Physical Activity, Sedentary Behaviour, Diet, and Cancer: An Update and Emerging New Evidence. The Lancet Oncology, 18(8): e457–e471. [3]   Hojman P, Gehl J, Christensen JF, et al., 2018, Molecular Mechanisms Linking Exercise to Cancer Prevention and Treatment. Cell Metabolism, 27(1): 10–21. [4]   Idorn M, Thor Straten P, 2017, Exercise and Cancer: From “Healthy” to “Therapeutic”? Cancer Immunology, Immunotherapy, 66(5): 667–671. [5]   Pedersen BK, Febbraio MA, 2012, Muscles, Exercise and Obesity: Skeletal Muscle as a Secretory Organ. Nature Reviews Endocrinology, 8(8): 457–465. [6]   Severinsen MCK, Pedersen BK, 2020, Muscle–Organ Crosstalk: The Emerging Roles of Myokines. Endocrine Reviews, 41(4): 594–609. [7]   Safdar A, Saleem A, Tarnopolsky MA, 2016, The Potential of Endurance Exercise-Derived Exosomes to Treat Metabolic Diseases. Nature Reviews Endocrinology, 12(9): 504–517. [8]   Whitham M, Parker BL, Friedrichsen M, et al., 2018, Extracellular Vesicles Provide a Means for Tissue Crosstalk During Exercise. Cell Metabolism, 27(2): 237–251.e4. [9]  Hawley JA, Hargreaves M, Joyner MJ, et al., 2014, Integrative Biology of Exercise. Cell, 159(4): 738–749. [10] Thomas RJ, Kenfield SA, Jimenez A, 2017, Exercise-Induced Biochemical Changes and Their Potential Influence on Cancer: A Scientific Review. British Journal of Sports Medicine, 51(8): 640–644. [11] Ruiz-Casado A, Martín-Ruiz A, Pérez LM, et al., 2017, Exercise and the Hallmarks of Cancer. Trends in Cancer, 3(6): 423–441. [12] Hanahan D, 2022, Hallmarks of Cancer: New Dimensions. Cancer Discovery, 12(1): 31–46. [13] Ellingsgaard H, Hojman P, Pedersen BK, 2019, Exercise and Health — Emerging Roles of IL-6. Current Opinion in Physiology, 10: 49–54. [14] Hojman P, 2017, Exercise Protects from Cancer Through Regulation of Immune Function and Inflammation. Biochemical Society Transactions, 45(4): 905–911. [15] Patel AV, Friedenreich CM, Moore SC, et al., 2019, American College of Sports Medicine Roundtable Report on Physical Activity, Sedentary Behavior, and Cancer Prevention and Control. Medicine & Science in Sports & Exercise, 51(11): 2391–2402. [16] Holmes MD, 2005, Physical Activity and Survival After Breast Cancer Diagnosis. JAMA, 293(20): 2479–2486. [17] Courneya KS, Vardy JL, O’Callaghan CJ, et al., 2025, Structured Exercise After Adjuvant Chemotherapy for Colon Cancer. New England Journal of Medicine, 393(1): 13–25. [18] Fearon K, Strasser F, Anker SD, et al., 2011, Definition and Classification of Cancer Cachexia: An International Consensus. The Lancet Oncology, 12(5): 489–495. [19] Cruz-Jentoft AJ, Bahat G, Bauer J, et al., 2019, Sarcopenia: Revised European Consensus on Definition and Diagnosis. Age and Ageing, 48(1): 16–31. [20] Shachar SS, Williams GR, Muss HB, et al., 2016, Prognostic Value of Sarcopenia in Adults with Solid Tumours: A Meta-Analysis and Systematic Review. European Journal of Cancer, 57: 58–67. [21] Buentzel J, Heinz J, Bleckmann A, et al., 2019, Sarcopenia as Prognostic Factor in Lung Cancer Patients: A Systematic Review and Meta-Analysis. Anticancer Research, 39(9): 4603–4612. [22] Aoi W, Naito Y, Takagi T, et al., 2013, A Novel Myokine, Secreted Protein Acidic and Rich in Cysteine (SPARC), Suppresses Colon Tumorigenesis via Regular Exercise. Gut, 62(6): 882–889. [23] Gannon NP, Vaughan RA, Garcia-Smith R, et al., 2015, Effects of the Exercise-Inducible Myokine Irisin on Malignant and Non-Malignant Breast Epithelial Cell Behavior In Vitro. International Journal of Cancer, 136(4): E197–E202. [24] Liu J, Song N, Huang Y, et al., 2018, Irisin Inhibits Pancreatic Cancer Cell Growth via the AMPK-mTOR Pathway. Scientific Reports, 8(1): 15247. [25] Gebhardt K, Krüger K, 2022, Supporting Tumor Therapy by Exercise: Boosting T Cell Immunity by Myokines. Signal Transduction and Targeted Therapy, 7(1): 292. [26] Pedersen KS, Gatto F, Zerahn B, et al., 2020, Exercise-Mediated Lowering of Glutamine Availability Suppresses Tumor Growth and Attenuates Muscle Wasting. iScience, 23(4): 100978. [27] Dethlefsen C, Hansen LS, Lillelund C, et al., 2017, Exercise-Induced Catecholamines Activate the Hippo Tumor Suppressor Pathway to Reduce Risks of Breast Cancer Development. Cancer Research, 77(18): 4894–4904. [28] Frühbeis C, Helmig S, Tug S, et al., 2015, Physical Exercise Induces Rapid Release of Small Extracellular Vesicles into the Circulation. Journal of Extracellular Vesicles, 4(1): 28239. [29] Brahmer A, Neuberger E, Esch-Heisser L, et al., 2019, Platelets, Endothelial Cells and Leukocytes Contribute to the Exercise-Triggered Release of Extracellular Vesicles into the Circulation. Journal of Extracellular Vesicles, 8(1): 1615820. [30] Estébanez B, Jiménez-Pavón D, Huang C, et al., 2021, Effects of Exercise on Exosome Release and Cargo in In Vivo and Ex Vivo Models: A Systematic Review. Journal of Cellular Physiology, 236(5): 3336–3353. [31] Pulliero A, You M, Chaluvally-Raghavan P, et al., 2020, Anticancer Effect of Physical Activity Is Mediated by Modulation of Extracellular MicroRNA in Blood. Oncotarget, 11(22): 2106–2119. [32] Siqueira IR, Batabyal RA, Freishtat R, et al., 2023, Potential Involvement of Circulating Extracellular Vesicles and Particles on Exercise Effects in Malignancies. Frontiers in Endocrinology, 14: 1121390. [33] Sadovska L, Auders J, Keiša L, et al., 2022, Exercise-Induced Extracellular Vesicles Delay the Progression of Prostate Cancer. Frontiers in Molecular Biosciences, 8: 784080. [34] Kurgan N, Tsakiridis E, Kouvelioti R, et al., 2017, Inhibition of Human Lung Cancer Cell Proliferation and Survival by Post-Exercise Serum Is Associated with the Inhibition of Akt, mTOR, p70 S6K, and Erk1/2. Cancers, 9(5): 46. [35] Orange ST, Jordan AR, Saxton JM, 2020, The Serological Responses to Acute Exercise in Humans Reduce Cancer Cell Growth In Vitro: A Systematic Review and Meta-Analysis. Physiological Reports, 8(22): e14635. [36] Orange ST, Jordan AR, Odell A, et al., 2022, Acute Aerobic Exercise-Conditioned Serum Reduces Colon Cancer Cell Proliferation In Vitro Through Interleukin-6-Induced Regulation of DNA Damage. International Journal of Cancer, 151(2): 265–274. [37] Metcalfe RS, Kemp R, Heffernan SM, et al., 2021, Anti-Carcinogenic Effects of Exercise-Conditioned Human Serum: Evidence, Relevance and Opportunities. European Journal of Applied Physiology, 121(8): 2107–2124. [38] Helmig S, Frühbeis C, Krämer-Albers E-M, et al., 2015, Release of Bulk Cell Free DNA During Physical Exercise Occurs Independent of Extracellular Vesicles. European Journal of Applied Physiology, 115(11): 2271–2280. [39] Pedersen L, Idorn M, Olofsson GH, et al., 2016, Voluntary Running Suppresses Tumor Growth Through Epinephrine- and IL-6-Dependent NK Cell Mobilization and Redistribution. Cell Metabolism, 23(3): 554–562. [40] Kurz E, Hirsch CA, Dalton T, et al., 2022, Exercise-Induced Engagement of the IL-15/IL-15Rα Axis Promotes Anti-Tumor Immunity in Pancreatic Cancer. Cancer Cell, 40(7): 720–737.e5. [41] Buss LA, Williams T, Hock B, et al., 2021, Effects of Exercise and Anti-PD-1 on the Tumour Microenvironment. Immunology Letters, 239: 60–71. [42] Betof AS, Lascola CD, Weitzel D, et al., 2015, Modulation of Murine Breast Tumor Vascularity, Hypoxia, and Chemotherapeutic Response by Exercise. JNCI: Journal of the National Cancer Institute, 107(5): djv040. [43] Wiggins JM, Opoku-Acheampong AB, Baumfalk DR, et al., 2018, Exercise and the Tumor Microenvironment: Potential Therapeutic Implications. Exercise and Sport Sciences Reviews, 46(1): 56–64. [44] Ashcraft KA, Warner AB, Jones LW, et al., 2019, Exercise as Adjunct Therapy in Cancer. Seminars in Radiation Oncology, 29(1): 16–24. [45] Campbell KL, Winters-Stone KM, Wiskemann J, et al., 2019, Exercise Guidelines for Cancer Survivors: Consensus Statement from International Multidisciplinary Roundtable. Medicine & Science in Sports & Exercise, 51(11): 2375–2390. [46] Fong DYT, Ho JWC, Hui BPH, et al., 2012, Physical Activity for Cancer Survivors: Meta-Analysis of Randomised Controlled Trials. BMJ, 344: e70. [47] Mustian KM, Alfano CM, Heckler C, et al., 2017, Comparison of Pharmaceutical, Psychological, and Exercise Treatments for Cancer-Related Fatigue. JAMA Oncology, 3(7): 961–968. [48] Sweegers MG, Altenburg TM, Chinapaw MJ, et al., 2018, Which Exercise Prescriptions Improve Quality of Life and Physical Function in Patients with Cancer During and Following Treatment? A Systematic Review and Meta-Analysis of Randomised Controlled Trials. British Journal of Sports Medicine, 52(8): 505–513. [49] Dieli-Conwright CM, Courneya KS, Demark-Wahnefried W, et al., 2018, Effects of Aerobic and Resistance Exercise on Metabolic Syndrome, Sarcopenic Obesity, and Circulating Biomarkers in Overweight or Obese Survivors of Breast Cancer: A Randomized Controlled Trial. Journal of Clinical Oncology, 36(9): 875–883.